Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar and Gemzar in advanced hepatocellular carcinoma
NCT00703365Phase 2Completed
- Sponsor
- Mahidol University
- Start
- Feb 2008
- Primary completion
- Jan 2010
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Mahidol University. Started Feb 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00703365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703365.